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We here show that tetradecanoyl phorbol acetate (TPA) and I-oleoyl 2-acetyl glycerol (OAG) cause the translocation 
of diacylglycxxol (DG) kinase from the cytosol to the membrane fractions in chick embryo fibroblast (CEF) cells. How- 
ever, this translocation is not marked in erbB-transformed chick embryo fibroblast (GEV) cells. The activities of phospha- 
tidylinositol (PI) and phosphatidylinositol4-phosphate (PIP) kinases in membrane fractions are not altered by TPA treat- 
ment in either CEF or GEV cells. Such reduced translocation of DG kinase by TPA is also observed in src-transformed 
cells, but not in myc-transformed cells. These results suggest hat the defect in DG kinase translocation may result in 
failure to suppress the overactivation of protein kinase C in erbB-2 and src-transformed cells, which may lead to cell 
growth and transformation. 
Diacylglycerol kinase; Translocation; Oncogene, erbB; Oncogene, src 
1. INTRODUCTION 
An avian retroviral oncogene, v-erbB, which is 
responsible for erythroblast and fibroblast 
transformation by avian erythroblastosis virus, has 
been shown to have extensive homology to the 
epidermal growth factor (EGF) receptor [l-3]. 
Therefore, the erbB gene product may induce a 
signal transduction system similar to that resulting 
from EGF receptor activation that leads to cell 
proliferation. Although for some growth factors 
the activation of inositol phospholipid metabolism 
has been suggested to play a role in the signal 
transduction that leads to cell proliferation [4-61, 
it has been reported that EGF does not stimulate 
inositol phospholipid metabolism in 3T3 fibro- 
blasts [7]. However, EGF is able to increase in- 
ositol phospholipid metabolism in A431 cells in 
which EGF receptors are overproduced. Similarly, 
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in erbB-transformed chick embryo fibroblast 
(GEV) cells, inositol phospholipid metabolism is 
markedly stimulated compared to that in normal 
chick embryo fibroblast (CEF) cells [8]. Moreover, 
the activities of three kinases that play important 
roles in inositol phospholipid metabolism, phos- 
phatidylinositol (PI) kinase, phosphatidylinositol 
4-phosphate (PIP) kinase and diacylglycerol (DG) 
kinase, are increased 3-5-fold in GEV cells, which 
is presumed to be related to cell growth enhance- 
ment in GEV cells. 
DG, produced by the phosphodiesteratic 
cleavage of polyphosphoinositides, plays a crucial 
role as an intracellular second messenger through 
the activation of protein kinase C [9,10]. In several 
oncogene-transformed cells, DG accumulation and 
subsequent activation of protein kinase C have 
been demonstrated [8,11], suggesting the possibili- 
ty that the alteration of DG attenuation causes cell 
transformation. The attenuation of DG is carried 
out by two pathways [12-151: phosphorylation by 
DG kinase, and degradation by DG lipase. The 
predominant pathway of attenuation is considered 
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to be via DG kinase. Therefore, DG kinase plays 
an important role in regulating the activity of pro- 
tein kinase C. The tumor promoter, tetradecanoyl 
phorbol acetate (TPA), is thought to bind protein 
kinase C at the DG-binding site instead of DG 
leading to the activation of the kinase [9,10]. Re- 
cent studies in cultured cells suggest hat transloca- 
tion of protein kinase C from cytosol to 
membranes occurs in response to DG or TPA and 
that translocation may be an important event in 
signal transduction [ 16,171. 
In this report, we examined the effect of TPA 
and DG, both protein kinase C activators, on the 
translocation of DG kinase [8], to clarify the 
regulatory mechanism of protein kinase C by DG 
kinase, and demonstrated that the translocation 
was relatively small in erbB- or src-transformed 
cells. 
2. MATERIALS AND METHODS 
2.1. Cell cullures 
Chick embryo fibroblast cells (CEF) were transformed by in- 
fection with gag-erbB (GEV), gag-myc (MC 29), avian 
erythroblastosis virus (AEV) or the Schmidt-Ruppin strain of 
Rous sarcoma virus of subgroup A (SRA). The cells were 
cultured in Eagle’s minimum essential medium supplemented 
with 10% heat inactivated fetal calf serum and 20 mM 
Hepes/NaOH buffer (pH 7.4). 
2.2. Preparation of cytosol and membrane fractions 
The cells (l-2 x 106) were treated with 100 ng/ml of TPA or 
OAG at 37°C for the indicated time and then washed with 
phosphate-buffered saline (PBS) three times and harvested with 
a rubber policeman. The cells were collected by centrifugation 
at 1000 x g for 5 min at 4°C and suspended in 50 mM Tris-HCI 
(pH 7.4) containing 1 mM ethylene glycol-bis-(&aminoethyl- 
ether)-N,N,N’,N’-methylsulfonylfluoride (5-6 x lo6 cells/500 
~1) and then disrupted by sonication at 0°C. The supernatant 
and membrane fractions were separated by centrifugation at 
100000 x g for 60 min. 
2.3. Assay of PI, PIP, and DG kinase activities 
The activities of PI, PIP and DG kinase were measured as 
described previously [II]. They are indicated as pmol/min per 
mg protein. 
3. RESULTS 
In normal chick embryo fibroblast cells (CEF) 
and also in erbB-transformed cells (GEV), most of 
the PI and PIP kinase activities are present in the 
membrane fraction. DG kinase activity, however, 
is detected in both the soluble and membrane frac- 
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tions. Whether both activities arise from the same 
enzyme species is not known, although the proper- 
ties of membrane-bound and soluble kinases are 
reported to be similar [18]. Activities of these 
kinases in GEV cells were higher than those in CEF 
cells as reported earlier [21]. TPA treatment did 
not change the activities of PI and PIP kinase in 
either GEV or CEF cells (table 1). However, DG 
kinase activity in the membrane fraction was 
dramatically increased (4.2-fold) in TPA-treated 
CEF cells. On the other hand, in GEV cells the ac- 
tivity was altered less significantly (1 .dfold) than 
in CEF cells. 
Fig. 1 shows the alterations in the distribution of 
DG kinase brought about by TPA treatment. In 
normal CEF cells, TPA increased the activity of 
DG kinase in the membrane fraction very marked- 
ly, while DG kinase activity in the cytosol was 
decreased. In addition, total DG kinase activity in 
homogenate fraction (data not shown) was not 
altered. The results suggest hat TPA causes the 
translocation of DG kinase from the cytosol to the 
membrane fraction. This translocation reaches a 
maximum 30 min after TPA treatment. At 30 min, 
DG kinase activity in the membrane fraction was 
increased 7-fold while that of the cytosol was 
decreased to 40% of the activity of untreated con- 
trols. On the other hand, TPA caused a slight 
translocation of DG kinase in GEV cells. The 
translocation of DG kinase occurred in a dose- 
dependent manner in CEF cells (fig.2A). High con- 
centrations of TPA (100 ng/ml) caused a 6-fold in- 
crease in DG kinase activity in the membrane 
fraction. However, in GEV cells, DG kinase activi- 
ty in the membrane fraction was not so evident as 
Table 1 
Effect of TPA on the activities of PI kinase, PIP kinase and DG 
kinase in membrane fraction 
Cells TPA treatment PI kinase PIP kinase DO kinase 
CEF - 1025 f 18 182 f 9 71+ 8 
+ 1059 f 21 178 + 8 431 + 13 
GEV _ 2279 f 29 407 f 18 240 + 10 
+ 2523 + 32 425 + 19 378 f 14 
Cells were treated with 100 ng/ml of TPA for 30 min at 37°C 
and then membrane fractions were isolated. Each kinase 
activity was assayed by incubating at 37°C for 3 min (PI 
kinase), 10 min (PIP and DG kinase). Activity expressed as 
pmol/min per mg protein 
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Fig.1. Time course of the increase in membrane-bound DG 
kinase activity caused by TPA. CEF and GEV cells were treated 
with TPA (100 ng/ml) at 37°C for the indicated time and then 
washed with phosphate-buffered saline (PBS) three times and 
harvested with a rubber policeman. The cells were collected and 
then disrupted by sonication at 0°C. The cytosol and membrane 
fractions were prepared as described and the DG kinase activity 
was measured. (A) DG kinase activity in cytosol (0) and 
membrane fractions (0) of TPA-treated CEF cells. (B) DG 
kinase activity in cytosol (0) and membrane fractions (0) of 
TPA-treated GEV cells. 
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Fig.2. Effect of TPA or DG kinase activity in membrane 
fractions. Cells were treated with various concentrations of 
TPA (A) or OAG (B) for 30 min at 37°C. After membrane 
fractions were isolated from CEF (0) or GEV (0) cells, DG 
kinase activity was measured. The activity of non-treated cells 
was taken as 100%. 
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Fig.3. Lineweaver-Burk plots of DG kinase activity in 
membrane fractions. CEF (A) and GEV (B) cells were treated 
with (0) or without TPA (0) (100 ng/ml) for 30 min at 37°C. 
After membrane fractions were isolated, DG kinase activity was 
measured with the various concentrations of DG. 
that in CEF cells, even at high concentrations of 
TPA. Similarly, the translocation of DG kinase 
was induced by OAG in a dose-dependent manner 
in CEF cells, although its effect was fairly weak 
compared to that by TPA (fig.2B). Also in this 
case, OAG did not induce a marked translocation 
in GEV cells. Lineweaver-Burk plots (fig.3) show 
that the V max value of DG kinase was increased in 
TPA-treated CEF cells compared to GEV cells 
without a change in the K, value, suggesting the 
increase in DG kinase protein rather than the 
modulation of DG kinase. 
To ascertain whether such a low translocation of 
DG kinase is also observed in other oncogene- 
induced transformed cells or not, we examined the 
effect of TPA on DG kinase translocation in src-, 
and myc-transformed cells (table 2). Consistent 
Table 2 
Effect of TPA on the activities of DG kinase in various cells 
Cell Onco- Membrane Cytosol 
strain gene 
Control TPA Control TPA 
CEF 71 + 8 431 r 13 288 + 9 179 + 5 
GEV v-erbB 240 + 10 378 + 14 444+11 325zt 9 
AEV v-erbB 264 + 9 394 + 14 435 + 12 304 * 10 
SRA v-src 233 f 8 324 f 6 336+ 8 255& 4. 
MC29 v-myc 121 f 6 588 r 12 264 + 5 139 f 4 
Cells were treated with TPA (100 ng/ml) for 30 min at 37°C 
and then membrane and cytosol fractions were separated. 
Activity expressed pmol/min per mg protein 
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with the above observation, translocation of DG 
kinase by TPA was not as evident in v-erbB or v- 
src-transformed cells as in normal cells. However, 
the translocation was marked in v-myc-trans- 
formed cells. These results suggest that trans- 
formed cells whose oncogene products are present 
in plasma membrane (erbB and src) may have 
some defect in translocation of DG kinase which is 
usually caused in response to DG formed in the 
membrane. 
Therefore, the increase in total DG kinase activity 
in src- and erbB-transformed cells may be due to 
oncogene products which have tyrosine kinase ac- 
tivity. From these results, we conclude that DG 
kinase translocation plays an important role in 
regulation of protein kinase C activity but in 
transformed cells, it does not function normally 
resulting in a sustained activation of protein 
kinase C. 
4. DISCUSSION REFERENCES 
We have shown that TPA causes a marked 
translocation of DG kinase from the cytosol to 
membrane fraction in CEF cells but not in erbB- 
and src-transformed cells. Recently, Besterman et 
al. [ 191 have reported that DG kinase is 
translocated from cytosol to the membrane frac- 
tion by the addition of DG. We have also found 
that DG kinase is translocated in response to TPA 
in neutrophils [29]. Therefore, TPA may cause 
translocation by a similar mechanism. 
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Considering that protein kinase C competes with 
DG kinase for DG and TPA, DG kinase may play 
an important role in the regulation of protein 
kinase C,activity. If this is the case, the transloca- 
tion of DG kinase to the membrane fraction may 
be necessary to suppress the overactivation of pro- 
tein kinase C, since protein kinase C also moves to 
membranes after DG or TPA treatment. 
Therefore,, a defect in the translocation of DG 
kinase may result in the failure to suppress protein 
kinase C, which may lead to cell growth and 
transformation. Indeed, the activity of membrane- 
associated protein kinase C was found to be in- 
creased in erbB-transformed cells compared to that 
in untransformed cells in accordance with an in- 
crease in DG content [8]. However, DG kinase ac- 
tivities both in membrane and cytosol fractions 
were found to be increased in src- and erbB- 
transformed cells as shown in table 2. This 
discrepancy suggests that the increment in DG 
kinase is not sufficient to eliminate DG increased 
by transformation, resulting in the accumulation 
of DG. Recently, we have found that in ras- 
transformed cells, DG kinase activity in membrane 
fractions is decreased and that in cytosol fractions 
is increased with no change in total activities [21]. 
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